Trial Profile
A Randomized, Open-label, 3-way Crossover Phase I Study in Type 2 Diabetes Mellitus Patients Treated With Metformin to Evaluate the Pharmacokinetics and Pharmacodynamics of Simvastatin During Coadministration With AZD1656 and to Evaluate the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2010
Price :
$35
*
At a glance
- Drugs AZD 1656 (Primary) ; Simvastatin (Primary)
- Indications Lipid metabolism disorders; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 05 Nov 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 05 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Apr 2010 New trial record